241 related articles for article (PubMed ID: 9452278)
21. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
Hasnan J; Jayaram G
Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
[TBL] [Abstract][Full Text] [Related]
22. Argyrophilic nucleolar organizer regions in benign and malignant mesothelial lesions.
Vacharadze K; Burkadze G; Turashvili G; Kiria N
Georgian Med News; 2005 Nov; (128):91-3. PubMed ID: 16369075
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of AgNOR score in differentiating benign from malignant pulmonary aspiration cytology.
Chern JH; Lee YC; Yang MH; Chang SC; Perng RP
Acta Cytol; 1997; 41(2):393-8. PubMed ID: 9100772
[TBL] [Abstract][Full Text] [Related]
24. Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations.
Chang S; Oh MH; Ji SY; Han J; Kim TJ; Eom M; Kwon KY; Ha SY; Choi YD; Lee CH; Lee Y; Jung SH
Pathol Int; 2014 Dec; 64(12):607-12. PubMed ID: 25376377
[TBL] [Abstract][Full Text] [Related]
25. Utility of AgNOR technique in distinguishing reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
Ramesh K; Gahukamble L; al Fituri O
Cent Afr J Med; 1994 Sep; 40(9):265. PubMed ID: 7834719
[No Abstract] [Full Text] [Related]
26. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
[TBL] [Abstract][Full Text] [Related]
27. [Mesothelioma and mesothelial hyperplasia].
Li LY; Luo WC; Zhu YJ
Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):328-31, 381. PubMed ID: 2269029
[TBL] [Abstract][Full Text] [Related]
28. Morphometric analysis of nucleolar organizer regions in benign and malignant peritoneal effusions using backscattered electron microscopy.
Lim SM; Duggan MA; Ruff M; Rahim S; McGregor SE; Green FH
J Pathol; 1992 Jan; 166(1):53-60. PubMed ID: 1538274
[TBL] [Abstract][Full Text] [Related]
29. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
30. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies.
Cagle PT; Churg A
Arch Pathol Lab Med; 2005 Nov; 129(11):1421-7. PubMed ID: 16253023
[TBL] [Abstract][Full Text] [Related]
31. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
Schned AR
Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
[TBL] [Abstract][Full Text] [Related]
32. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.
Attanoos RL; Griffin A; Gibbs AR
Histopathology; 2003 Sep; 43(3):231-8. PubMed ID: 12940775
[TBL] [Abstract][Full Text] [Related]
33. Significance of AgNOR count in differentiating malignant cells from reactive mesothelial cells in serous effusions.
Sujathan K; Kannan S; Pillai KR; Chandralekha B; Amma NS; Nair MK
Acta Cytol; 1996; 40(4):724-8. PubMed ID: 8693893
[TBL] [Abstract][Full Text] [Related]
34. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
Huang MS; Tsai MS; Hwang JJ; Wang TH
Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
[TBL] [Abstract][Full Text] [Related]
36. New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?
Churg A; Sheffield BS; Galateau-Salle F
Arch Pathol Lab Med; 2016 Apr; 140(4):318-21. PubMed ID: 26288396
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of argyrophilic nucleolar organizer regions score to differentiate suspicious malignancy in pulmonary cytology.
Chern JH; Lee YC; Yang MH; Chang SC; Perng RP
Chest; 1997 Jun; 111(6):1591-6. PubMed ID: 9187179
[TBL] [Abstract][Full Text] [Related]
38. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation.
Shi M; Fraire AE; Chu P; Cornejo K; Woda BA; Dresser K; Rock KL; Jiang Z
Am J Surg Pathol; 2011 Jun; 35(6):878-82. PubMed ID: 21566519
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of malignant from normal and reactive mesothelial cells by the argyrophil technique for nucleolar organiser region associated proteins.
Ayres JG; Crocker JG; Skilbeck NQ
Thorax; 1988 May; 43(5):366-70. PubMed ID: 2461601
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of nucleoli and nucleolar organizer regions in cultured primary human normal, reactive and malignant mesothelial cells.
Ribotta M; Donna A; Betta PG; Libener R; Bellingeri D; Robutti F
Pathol Res Pract; 1992 Jun; 188(4-5):536-40. PubMed ID: 1409084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
